ADVERTISEMENT
oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
China Approves Alzheimer’s Treatment that Targets the Microbiome
China Approves Alzheimer’s Treatment that Targets the Microbiome

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

neurodegeneration, disease & medicine, drug development, microbiology

Sorry, no results found.

We tried our best, but we couldn't find any articles relating to .

ADVERTISEMENT